Expression of breast cancer specific gene-1 (BCSG-1/γ-synuclein) is associated with tumour grade but not with clinical outcome of patients with breast cancer

Oncology Reports

Volumn 16, Issue 1, 2006, Pages 207-212

  Martin, Tracey A ^a   Gomez, Kelvin ^a   Watkins, Gareth ^a   Douglas Jones, Anthony ^a   Mansel, Robert E ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Breast cancer specific gene 1; Differentiation; Metastasis; SNCG; Survival; synuclein

Indexed keywords

GAMMA SYNUCLEIN; MESSENGER RNA; PRIMER DNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TGM3 PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CHEMISTRY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METASTASIS; PROGNOSIS; TIME; TREATMENT OUTCOME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA PRIMERS; FEMALE; FOLLOW-UP STUDIES; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; RNA, MESSENGER; TIME FACTORS; TRANSGLUTAMINASES; TREATMENT OUTCOME;

EID: 33750719588     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.1.207     Document Type: Article

References (20)

1. Jiang Y, Liu YE, Goldberg ID and Shi YE: Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Cancer Res 64: 4539-4546, 2004. (Pubitemid 38856926)
2. Jia T, Liu YE, Liu J and Shi YE: Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 59: 742-771, 1999.
3. Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J and Shi YE: Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 63: 3899-3903, 2003. (Pubitemid 36917902)
4. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, Zhang Y, Ding X, Jiang Y and Shi YE: Stage-specific expression of breast cancer-specific gene gamma-synuclein. Cancer Epidemiol Biomarkers Prev 12: 920-925, 2003. (Pubitemid 37151530)
5. Zhou CQ, Liu S, Xue LY, Wang YH, Zhu HX, Lu N and Xu NZ: Down-regulation of gamma-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 9: 1900-1903, 2003. (Pubitemid 37168409)
6. Jiang WG, Watkins G, Lane J, Douglas-Jones A, Cunnick GH, Mokbel M and Mansel RE: Prognostic value of Rho family and and rho-GDIs in breast cancer. Clin Cancer Res 9: 6432-6440, 2003.
7. Jiang WG, Douglas-Jones A and Mansel RE: Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int J Cancer 106: 752-757, 2003.
8. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K and Mansel RE: Differential expression of the CCN family members, Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11: 781-791, 2004. (Pubitemid 40065551)
9. Jiang WG, Davies G and Fodstad O: Com-1 p8 in oestrogen regulated growth of breast cancer cells, the ER-β connection. Biochem Biophys Res Commun 330: 253-262, 2005. (Pubitemid 40394960)
10. Davies G, Jiang WG and Mason MD: Cell-cell adhesion and signalling intermediates in human prostate cancer. J Urol 163: 985-992, 2000.
11. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, Terai A, Arai Y, Iwamura H, Kawakita M and Yoshiki T: Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci 95: 955-961, 2004. (Pubitemid 40089587)
12. Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB and Chiao PJ: Overexpression of synuclein-gamma in pancreatic adenocarcinoma. Cancer 101: 58-65, 2004.
13. Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S and Motoyama T: Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res 10: 2447-2451, 2004. (Pubitemid 38445705)
14. Andringa G, Lam KY, Chegary M, Wang X, Chase TN and Bennett MC: Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. FASEB J 18: 932-934, 2004.
15. Junn E, Ronchetti RD, Quezado MM, Kim SY and Mouradian MM: Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 100: 2047-2052, 2003. (Pubitemid 36254571)
16. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ and Godwin AK: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163, 2000. (Pubitemid 30233219)
17. Lu A, Gupta A, Li C, Ahlborn TE, Ma Y, Shi EY and Liu J: Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 20: 5173-5185, 2001. (Pubitemid 32844046)
18. Gupta A, Godwin AK, Vanderveer L, Lu A and Liu J: Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63: 664-673, 2003. (Pubitemid 36158146)
19. Pan ZZ, Bruening W, Giasson BI, Lee VM and Godwin AK: Gamma-synuclein promotes cancer cell survival and inhibits stress-and chemotherapy drug-induced apoptosis by modulating MAPK pathways. J Biol Chem 277: 35050-35060, 2002.
20. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE and Surguchov AP: Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 410: 167-176, 2003. (Pubitemid 36268809)